Literature DB >> 23054659

Catheter ablation for long-standing persistent atrial fibrillation in patients who have failed electrical cardioversion.

Fei Lü1, Wayne O Adkisson, Taibo Chen, Baris Akdemir, David G Benditt.   

Abstract

Ablation outcomes in 22 consecutive long-standing persistent atrial fibrillation (LPAF) patients with failed direct current cardioversion (DCCV; group 1) were compared with findings in 22 consecutive LPAF patients who had successful DCCV (control 1) and 22 consecutive patients with paroxysmal atrial fibrillation (AF; control 2). All patients underwent a stepwise progressive ablation protocol (pulmonary vein isolation, ablation of complex fractionated atrial electrogram, and repeat ablation of any induced atrial tachycardias). Over 18-month follow-up, 59 % of group 1 patients remained in sinus rhythm without recurrent AF, compared to 64 % and 77 % in controls 1 and 2, respectively. The procedure time was longer in LPAF with a higher procedure complication risk in these 44 LPAF patients (5 % vs. 0 %) than in patients with paroxysmal AF. Our data suggest that catheter ablation provides a practical treatment option with moderate efficacy for restoring sinus rhythm in LPAF patients after failed DCCV.

Entities:  

Mesh:

Year:  2012        PMID: 23054659     DOI: 10.1007/s12265-012-9411-6

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  24 in total

1.  2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  L Samuel Wann; Anne B Curtis; Craig T January; Kenneth A Ellenbogen; James E Lowe; N A Mark Estes; Richard L Page; Michael D Ezekowitz; David J Slotwiner; Warren M Jackman; William G Stevenson; Cynthia M Tracy; Valentin Fuster; Lars E Rydén; David S Cannom; Jean-Yves Le Heuzey; Harry J Crijns; James E Lowe; Anne B Curtis; S Bertil Olsson; Kenneth A Ellenbogen; Eric N Prystowsky; Jonathan L Halperin; Juan Luis Tamargo; G Neal Kay; L Samuel Wann; Alice K Jacobs; Jeffrey L Anderson; Nancy Albert; Judith S Hochman; Christopher E Buller; Frederick G Kushner; Mark A Creager; Erik Magnus Ohman; Steven M Ettinger; William G Stevenson; Robert A Guyton; Lynn G Tarkington; Jonathan L Halperin; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2010-12-21       Impact factor: 24.094

2.  Circumferential pulmonary-vein ablation for chronic atrial fibrillation.

Authors:  Hakan Oral; Carlo Pappone; Aman Chugh; Eric Good; Frank Bogun; Frank Pelosi; Eric R Bates; Michael H Lehmann; Gabriele Vicedomini; Giuseppe Augello; Eustachio Agricola; Simone Sala; Vincenzo Santinelli; Fred Morady
Journal:  N Engl J Med       Date:  2006-03-02       Impact factor: 91.245

3.  Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias.

Authors:  Michel Haïssaguerre; Mélèze Hocini; Prashanthan Sanders; Frederic Sacher; Martin Rotter; Yoshihide Takahashi; Thomas Rostock; Li-Fern Hsu; Pierre Bordachar; Sylvain Reuter; Raymond Roudaut; Jacques Clémenty; Pierre Jaïs
Journal:  J Cardiovasc Electrophysiol       Date:  2005-11

4.  Randomized comparison of encircling and nonencircling left atrial ablation for chronic atrial fibrillation.

Authors:  Hakan Oral; Aman Chugh; Eric Good; Petar Igic; Darryl Elmouchi; David R Tschopp; S Scott Reich; Frank Bogun; Frank Pelosi; Fred Morady
Journal:  Heart Rhythm       Date:  2005-11       Impact factor: 6.343

5.  Pulmonary vein antral isolation and nonpulmonary vein trigger ablation without additional substrate modification for treating longstanding persistent atrial fibrillation.

Authors:  David Lin; David S Frankel; Erica S Zado; Edward Gerstenfeld; Sanjay Dixit; David J Callans; Michael Riley; Mathew Hutchinson; Fermin Garcia; Rupa Bala; Ralph Verdino; Joshua Cooper; Francis E Marchlinski
Journal:  J Cardiovasc Electrophysiol       Date:  2012-04-17

Review 6.  Outcomes of long-standing persistent atrial fibrillation ablation: a systematic review.

Authors:  Anthony G Brooks; Martin K Stiles; Julien Laborderie; Dennis H Lau; Pawel Kuklik; Nicholas J Shipp; Li-Fern Hsu; Prashanthan Sanders
Journal:  Heart Rhythm       Date:  2010-01-22       Impact factor: 6.343

7.  Trigger-based mechanism of the persistence of atrial fibrillation and its impact on the efficacy of catheter ablation.

Authors:  Koichi Inoue; Toshiya Kurotobi; Ryusuke Kimura; Yuko Toyoshima; Norihisa Itoh; Masaharu Masuda; Yoshiharu Higuchi; Motoo Date; Yasushi Koyama; Atsunori Okamura; Katsuomi Iwakura; Kenshi Fujii
Journal:  Circ Arrhythm Electrophysiol       Date:  2011-10-31

8.  Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation.

Authors:  Hakan Oral; Aman Chugh; Mehmet Ozaydin; Eric Good; Jackie Fortino; Sundar Sankaran; Scott Reich; Petar Igic; Darryl Elmouchi; David Tschopp; Alan Wimmer; Sujoya Dey; Thomas Crawford; Frank Pelosi; Krit Jongnarangsin; Frank Bogun; Fred Morady
Journal:  Circulation       Date:  2006-08-14       Impact factor: 29.690

9.  Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats.

Authors:  M C Wijffels; C J Kirchhof; R Dorland; M A Allessie
Journal:  Circulation       Date:  1995-10-01       Impact factor: 29.690

10.  A randomized assessment of the incremental role of ablation of complex fractionated atrial electrograms after antral pulmonary vein isolation for long-lasting persistent atrial fibrillation.

Authors:  Hakan Oral; Aman Chugh; Kentaro Yoshida; Jean F Sarrazin; Michael Kuhne; Thomas Crawford; Nagib Chalfoun; Darryl Wells; Warangkna Boonyapisit; Srikar Veerareddy; Sreedhar Billakanty; Wai S Wong; Eric Good; Krit Jongnarangsin; Frank Pelosi; Frank Bogun; Fred Morady
Journal:  J Am Coll Cardiol       Date:  2009-03-03       Impact factor: 24.094

View more
  1 in total

1.  Vagus nerve stimulation: An evolving adjunctive treatment for cardiac disease.

Authors:  Barış Akdemir; David G Benditt
Journal:  Anatol J Cardiol       Date:  2016-10       Impact factor: 1.596

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.